News

Good news, vegans: A new study finds that kimchi made without fish products has the same type of bacteria as more traditionally made kimchi. That finding suggests that any “probiotic” benefits associated with traditional kimchi could be present in vegan versions as well.

Researchers have discovered why the brain’s olfactory system is so remarkably consistent between individuals, even though the wiring of brain cells in this region differs greatly from person to person.

Nearly a thousand years ago, occupants of the Mule Spring Rockshelter in present-day Nevada chowed down on agave leaves, only leaving behind the stringy fibers known as 'quids', which were spat out. Now, these quids have been analyzed, producing valuable DNA evidence of tribal history in the area.

Scientists at Cold Spring Harbor Laboratory (CSHL) have identified a therapeutic RNA molecule that corrects the error in genetic processing that leads to familial dysautonomia, a rare inherited neurodegenerative disorder.

Optogenetics allows manipulation of cells using light, usually in concert with genetic modification of the cells to make them light-sensitive. Now, tiny silicon implants could remove the need for any genetic modification at all.

Women with an aggressive form of breast cancer who have faults in their BRCA genes do much better on chemotherapy drug carboplatin than standard treatment, a major clinical trial reports.

Researchers found that women with advanced ‘triple-negative’ breast cancer who had inherited a BRCA mutation were twice as likely to benefit from carboplatin as docetaxel, which is currently standard of care for these patients.

Synthetic biologists have generated lab-grown red blood cells with rare blood group types that could one day be used to help patients who cannot be matched with donor blood.

The task of building an entire organism from a single-cell is unbelievably complex, and yet happens across multicellular life. New studies now have traced individual cells' division and growth over the first 24 hours of life in two key organisms.

Researchers are a step closer to growing blood cells customized to the special needs of transfusion patients with rare blood groups.

A nucleic acid-detecting diagnostics platform that harnesses the gene editing technology CRISPR was announced today by the newly-launched Mammoth Biosciences, which says the technology could change how we diagnose disease.